SIA "UNIFARMA"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 143 875 € (2% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2008–2025
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||||||||||||
| Total current assets | 1 981 124 | 1 752 402 | 1 889 487 | 2 185 069 | 2 476 537 | 3 727 239 | 3 818 563 | 3 667 524 | 3 750 454 | 3 121 855 | 2 665 055 | 3 477 641 | 3 931 242 | 5 079 223 | 6 247 312 | 7 615 529 | 8 479 940 | 7 502 116 |
| Total non-current assets | 779 191 | 962 641 | 1 293 174 | 2 201 174 | 2 220 242 | 3 006 848 | 2 901 647 | 2 918 226 | 2 817 863 | 2 340 818 | 2 226 842 | 2 000 806 | 2 105 507 | 2 299 219 | 1 914 349 | 1 933 453 | 2 386 391 | 5 586 442 |
| Total assets | 2 760 315 | 2 715 043 | 3 182 661 | 4 386 243 | 4 696 779 | 6 734 087 | 6 720 210 | 6 585 750 | 6 568 317 | 5 462 673 | 4 891 897 | 5 478 447 | 6 036 749 | 7 378 442 | 8 161 661 | 9 548 982 | 10 866 331 | 13 088 558 |
| Balance sheet — liabilities and equity | ||||||||||||||||||
| Current liabilities | 2 919 356 | 2 675 792 | 3 054 477 | 3 914 275 | 4 266 192 | 6 309 869 | 7 721 661 | 6 572 796 | 6 586 768 | 5 285 327 | 4 188 903 | 3 701 488 | 3 362 519 | 3 371 804 | 2 575 206 | 2 105 751 | 2 031 646 | 2 082 298 |
| Non-current liabilities | 0 | 0 | 0 | 320 507 | 266 457 | 180 750 | 88 688 | 48 758 | 0 | 9381 | 2787 | 0 | 0 | 0 | 0 | 0 | 56 737 | 914 410 |
| Total liabilities | 2 919 356 | 2 675 792 | 3 054 477 | 4 234 782 | 4 532 649 | 6 490 619 | 7 810 349 | 6 621 554 | 6 586 768 | 5 294 708 | 4 191 690 | 3 701 488 | 3 362 519 | 3 371 804 | 2 575 206 | 2 105 751 | 2 088 383 | 2 996 708 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -491 976 | 199 434 | 97 786 | 62 866 | 24 144 | -19 144 | -1 314 094 | 1 059 525 | 214 973 | 186 421 | 532 243 | 1 126 752 | 1 097 271 | 1 427 408 | 1 746 817 | 2 031 543 | 1 560 087 | 1 457 777 |
| Total equity | -168 051 | 31 383 | 114 741 | 130 066 | 152 210 | 197 431 | -1 116 661 | -56 988 | -18 451 | 167 965 | 700 207 | 1 776 959 | 2 674 230 | 4 006 638 | 5 586 455 | 7 443 231 | 8 777 948 | 10 091 850 |
| Income statement | ||||||||||||||||||
| Sales revenue | 2 113 685 | 2 505 518 | 2 410 752 | 3 019 583 | 2 806 864 | 4 522 785 | 4 121 536 | 4 027 069 | 3 512 951 | 3 742 434 | 3 398 042 | 3 294 197 | 3 894 236 | 5 215 281 | 4 436 583 | 4 750 019 | 6 118 126 | 6 836 102 |
| Operating profit | -99 268 | 139 676 | -96 669 | 244 330 | 152 089 | -444 813 | 19 245 | 384 378 | 186 619 | 161 796 | 511 225 | 1 048 386 | 1 123 667 | 1 426 829 | 1 765 897 | 2 049 890 | 1 546 396 | 1 404 483 |
| Profit before income tax | -492 191 | 198 539 | 63 708 | 81 567 | 39 119 | 3664 | -1 302 269 | 1 049 112 | 214 973 | 189 713 | 534 243 | 1 128 060 | 1 147 737 | 1 454 289 | 1 791 207 | 2 076 542 | 1 618 002 | 1 486 722 |
| Profit for the reporting year | -491 976 | 199 434 | 97 786 | 62 866 | 24 144 | -19 144 | -1 314 094 | 1 059 525 | 214 973 | 186 421 | 532 243 | 1 126 752 | 1 097 271 | 1 427 408 | 1 746 817 | 2 031 543 | 1 560 087 | 1 457 777 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||||||||||||
| Employees | 14 | 14 | 13 | 43 | 14 | 15 | 50 | 47 | 12 | 13 | 13 | 13 | 13 | 15 | 17 | 16 | 19 | 20 |
| Calculated dividend | 55 316 | 50 188 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50 000 | 200 000 | 95 000 | 167 000 | 174 767 | 225 370 | 143 875 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: SIA "UNIFARMA"
Overview
SIA "UNIFARMA" (reg. no. 40003472521) is a limited liability company. The company was registered in 1999 and has been in the register for 26 years. Registered address: Rīga, Vangažu iela 23.
Financial results
Revenue in 2025 was 6 836 102 €, up 11,7% on the previous year (6 118 126 €). From 2008 to 2025, revenue grew by an average of 7,1% per year. This is the company's highest revenue among the published years (2008–2025). Net profit for 2025 was 1 457 777 € (21,3% of revenue). The company was profitable in 15 of the 18 published years. In 2025 the company had 20 employees (19 a year earlier). Revenue per employee was 341 805 €. At the end of 2025, total assets were 13 088 558 € and equity 10 091 850 € (77,1% of assets).
Management and owners
The board has 2 members. The sole owner of the company is a private individual. The company holds stakes in 2 active Latvian companies.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.